Dialysis News and Research

Latest Dialysis News and Research

High risk of serious complications or death in children with SP-HUS

Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.

30 Aug 2011

Researchers identify molecule that can stop the formation of amyloid fibrils

A molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified by researchers at the University of Leeds.

29 Aug 2011

Redesigned vancomycin can kill deadliest antibiotic-resistant bacteria

A team of scientists from The Scripps Research Institute have successfully reengineered an important antibiotic to kill the deadliest antibiotic-resistant bacteria.

25 Aug 2011

Kibow renews exclusive worldwide veterinary licensing and marketing agreement

Kibow Biotech, Inc. today announced that it has renewed its exclusive worldwide licensing and marketing agreement with the current licensing partner specializing in animal health.

24 Aug 2011

Celldex announces key in vivo efficacy results of CDX-1135 in Dense Deposit Disease

Celldex Therapeutics, Inc. today announced key in vivo efficacy data for its CDX-1135 program from a collaboration with Drs. Richard Smith and Carla Nester at the University of Iowa.

24 Aug 2011

CJASN: Most dialysis patients are not prepared to effectively handle disasters

Most dialysis patients are not prepared to effectively handle man-made or natural disasters, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

19 Aug 2011

H1N1 vaccine safe, effective for hemodialysis and kidney transplant patients

When the influenza A (H1N1) virus swept around the world in spring 2009, infection was presumed to be more common in immunosuppressed patients, such as those who have had a kidney transplant. Later that year, the International Societies of Transplantation recommended that transplant recipients receive at least one dose of the H1N1 vaccine, although there was no information on the efficacy of the vaccine in that population.

19 Aug 2011

Minocycline, EDTA may combat catheter-related bacterial infections in dialysis patients

Antibiotics can help ward off serious bacterial infections in kidney disease patients who use tubes called catheters for their dialysis treatments. But if antibiotics are used too often, "super bugs" may crop up that are resistant to the drugs.

19 Aug 2011

FDA assigns PDUFA action date for review of Affymax peginesatide NDA

Affymax, Inc. today announced that the U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date of March 27, 2012 for the review of the investigational agent peginesatide New Drug Application.

12 Aug 2011

Nephros submits new 510(k) application with FDA for clearance of hemodiafiltration system

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced that on August 11, 2011 it filed a 510(k) application with the Food and Drug Administration (FDA) for clearance of its hemodiafiltration system.

12 Aug 2011

FDA acceptance of peginesatide NDA triggers $10M milestone payment to Affymax

Affymax, Inc. today announced that it has received a $10 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize peginesatide (formerly known as Hematide™), Affymax's investigational drug for the treatment of anemia in chronic renal failure patients.

10 Aug 2011

Young blacks with kidney disease more likely to die on dialysis than whites

For years, medical studies have reached the same conclusion: African-American patients do better on kidney dialysis than their white counterparts. But new Johns Hopkins research, published in the Journal of the American Medical Association, shows that younger blacks - those under the age of 50 - actually do much worse on dialysis than equally sick whites who undergo the same blood-filtering process.

10 Aug 2011

CMS unveils updated website to help consumers compare quality data

Officials from the Centers for Medicare and Medicaid Services said Friday that site includes updated data to help consumers compare hospitals, physicians, nursing homes, home care or dialysis providers.

8 Aug 2011

Pre-emptive insulin therapy reduces risk of diabetes mellitus after kidney transplantation

Up to 30 percent of all patients develop diabetes mellitus within the first year after a kidney transplantation. This high rate could soon fall rapidly. A Medical University of Vienna research team at Vienna General Hospital's University Department of Internal Medicine III has discovered in the context of a study that pre-emptive insulin therapy drastically reduces this rate.

8 Aug 2011

NxStage second quarter revenue increases 22% to $53.8 million

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record financial results for the second quarter of 2011 ended June 30, 2011, with total revenue well above the top end of its guidance range.

3 Aug 2011

Roundup: Atlanta hospital facing questions about extending dialysis care to immigrants; Fla. to limit HMO choices for state workers

The agreement providing dialysis for immigrants who were former Grady patients expires at the end of August, and it's unclear what will happen next. ... Grady's financial situation has deteriorated recently, and its losses this year could reach $20 million or more. Meanwhile, the hospital continues to shoulder an enormous financial burden in caring for uninsured patients, including immigrants, providing more than $200 million in indigent care annually.

3 Aug 2011

Study shows fall in blood pressure during dialysis for patients increases risk of blood clotting

A sudden drop in blood pressure while undergoing dialysis has long vexed many kidney patients. Side effects associated with this situation over the long term range from stroke to seizure to heart damage to death.

30 Jul 2011

Amgen reports 8% increase in second quarter total product sales to $3,893 million

Amgen reported total revenue increased 4 percent during the second quarter of 2011 to $3,959 million versus $3,804 million in the second quarter of 2010. Total product sales increased 8 percent in the second quarter of 2011 to $3,893 million versus $3,613 million in the second quarter of 2010. The increase in total revenue in the second quarter of 2011 included a decline in other revenue due to certain milestone payments earned in the second quarter of 2010.

29 Jul 2011

Reprogrammed kidney cells could make transplants and dialysis things of the past

Approximately 60 million people across the globe have chronic kidney disease (CKD), and many will need dialysis or a transplant. Breakthrough research published in the Journal of the American Society Nephrology indicates that patients' own kidney cells can be gathered and reprogrammed.

28 Jul 2011

FDA accepts peginesatide NDA for anemia associated with CKD

Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for peginesatide (formerly known as Hematide™) for the treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis.

27 Jul 2011

Dialysis News and Research

Latest Dialysis News and Research

High risk of serious complications or death in children with SP-HUS

Researchers identify molecule that can stop the formation of amyloid fibrils

Redesigned vancomycin can kill deadliest antibiotic-resistant bacteria

Kibow renews exclusive worldwide veterinary licensing and marketing agreement

Celldex announces key in vivo efficacy results of CDX-1135 in Dense Deposit Disease

CJASN: Most dialysis patients are not prepared to effectively handle disasters

H1N1 vaccine safe, effective for hemodialysis and kidney transplant patients

Minocycline, EDTA may combat catheter-related bacterial infections in dialysis patients

FDA assigns PDUFA action date for review of Affymax peginesatide NDA

Nephros submits new 510(k) application with FDA for clearance of hemodiafiltration system

FDA acceptance of peginesatide NDA triggers $10M milestone payment to Affymax

Young blacks with kidney disease more likely to die on dialysis than whites

CMS unveils updated website to help consumers compare quality data

Pre-emptive insulin therapy reduces risk of diabetes mellitus after kidney transplantation

NxStage second quarter revenue increases 22% to $53.8 million

Roundup: Atlanta hospital facing questions about extending dialysis care to immigrants; Fla. to limit HMO choices for state workers

Study shows fall in blood pressure during dialysis for patients increases risk of blood clotting

Amgen reports 8% increase in second quarter total product sales to $3,893 million

Reprogrammed kidney cells could make transplants and dialysis things of the past

FDA accepts peginesatide NDA for anemia associated with CKD

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dialysis News and Research

Latest Dialysis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in